1. Home
  2. AGIG vs ATNM Comparison

AGIG vs ATNM Comparison

Compare AGIG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGIG

Abundia Global Impact Group Inc. Common stock

N/A

Current Price

$1.15

Market Cap

49.4M

Sector

Energy

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.11

Market Cap

42.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGIG
ATNM
Founded
N/A
2000
Country
United States
United States
Employees
2
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
42.0M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
AGIG
ATNM
Price
$1.15
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
116.4K
94.1K
Earning Date
05-19-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
N/A
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$1.01
$0.95
52 Week High
$5.31
$1.95

Technical Indicators

Market Signals
Indicator
AGIG
ATNM
Relative Strength Index (RSI) 48.39 41.82
Support Level $1.04 $0.99
Resistance Level $1.68 $1.38
Average True Range (ATR) 0.07 0.07
MACD 0.01 -0.01
Stochastic Oscillator 40.94 1.14

Price Performance

Historical Comparison
AGIG
ATNM

About AGIG Abundia Global Impact Group Inc. Common stock

Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: